NCT02547298

Brief Summary

Patients who are already scheduled to have a gynecologic, urologic or uro-gynecologic procedure involving cystoscopy (a lighted scope is used to look inside the bladder) under anesthesia will be approached to participate in the study. Once prospective study subjects are consented, they will be requested to complete the study questionnaires. At the time of the procedure, during the cystoscopy, patients will undergo hydrodistension (stretching the bladder with fluid). Photographic images of the bladder will be collected, to be later analyzed by examiners. Patients who have positive findings for interstitial cystitis during cystoscopy with hydrodistension, will be notified of the findings after the procedure. They will be asked to fill out an additional, previously completed questionnaire at the time of a follow-up visit, during a phone interview or responding to the questionnaire via a secure web site. These patients will be treated for interstitial cystitis by their primary providers as clinically indicated.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
734

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 26, 2015

Completed
16 days until next milestone

First Posted

Study publicly available on registry

September 11, 2015

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 18, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 18, 2018

Completed
Last Updated

January 26, 2022

Status Verified

January 1, 2022

Enrollment Period

2.6 years

First QC Date

August 26, 2015

Last Update Submit

January 11, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Correlation between severity of urinary symptoms and IC-like findings on cystoscopy with hydrodistension.

    Change From Baseline in Pain on the 11 point Short Pain Scale (SPS-11).

    up to 5 years

Secondary Outcomes (7)

  • The association of GI symptoms with IC-like findings on cystoscopy with hydrodistension

    up to 5 years

  • The correlation between O'Leary-Sant score and cystoscopic findings

    up to 5 years

  • The correlation between PUF score and cystoscopic findings

    up to 5 years

  • The association between cystoscopic and previous urologic or gynecologic surgeries

    up to 5 years

  • The number of patients with interstitial cystitis who's symptoms improve after cystoscopy with hydrodistension

    up to 5 years

  • +2 more secondary outcomes

Study Arms (1)

All participants

All participants will be filling out questionnaires and undergoing cystoscopy with hydrodistension for evaluative reasons

Eligibility Criteria

Age18 Years - 90 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All women scheduled to undergo cystoscopy or cystoscopy with hydrodistension in an academic institution, within the benign gynecologic division with eligibility criteria as above.

You may qualify if:

  • Female
  • Patients must be at least 18 years of age.
  • Patients must have been previously scheduled for a surgical procedure that includes cystoscopy under anesthesia or cystoscopy with hydrodistension under anesthesia.
  • Patients must be able to provide written informed consent.

You may not qualify if:

  • pregnancy
  • planned cystotomy
  • incidental cystotomy during surgery - patient not eligible for hydrodistention
  • patient's age \> 90
  • history of pelvic radiation 6, Previous or newly diagnosed bladder tumor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Mary's Health Center

St Louis, Missouri, 63117, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Urine samples retained

MeSH Terms

Conditions

Cystitis, Interstitial

Condition Hierarchy (Ancestors)

CystitisUrinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Ioana Marcu, MD

    St. Louis University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

August 26, 2015

First Posted

September 11, 2015

Study Start

June 1, 2015

Primary Completion

January 18, 2018

Study Completion

January 18, 2018

Last Updated

January 26, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations